The study, published in JAMA Network Open, analyzed health records for more than 600,000 children 10 to 19 years old between January 2020 and December 2022. The participants were categorized into two equal groups: those with a COVID infection and those with other respiratory infections such as influenza and rhinovirus.
The study also found children who were obese that had COVID-19 were 100% more likely to develop Type 2 diabetes compared to obese children with other respiratory infections.
COVID-19 vaccines were not available to all children until October 2021, a year into the study timeframe analyzed. Vaccines may reduce the risk of a diabetes diagnosis, but more research is required.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
